Abstract
Biotechnology and pharmaceutical industries are required to use in vivo tests, in addition to in vitro tests, for drug evaluation. These in vivo tests are carried out on nonhuman animals, and drug regulating authorities insist on rigorous animal testing before issuing license for human use. For various reasons (Wales, Animal testing. http://en.wikipedia.org/wiki/Animal_testing), there is a global move towards minimizing the in vivo tests. This article presents a case study carried out at M/s Bharat Biotech International Limited, Hyderabad, on minimizing in vivo tests for evaluating efficacy of recombinant Hepatitis B vaccine produced by the company. Exploring the past data using different statistical methods, the study recommends a statistical procedure to assess the efficacy of the vaccine produced in each batch based on in vitro test result and provides a decision rule on when to conduct in vivo test. The benefits of the study are discussed. The approach suggested in this work may be extended to similar cases where in vivo tests are involved. It is hoped that this study will be contributing to the cause of minimizing in vivo tests.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Balcombe, J.: The Use of Animals in Higher Education, Problems, Alternatives & Recommendations. The Humane Society Press, Washington, DC (2000). http://www.hsus.org/web-files/PDF/ARI/ARIS_The_Use_Of_Animals_InHigher_Education.pdf. Cited 29 Oct 2000
Berry, D.S.: Statistical Methodology in the Pharmaceutical Sciences. Marcel Dekker, New York (1990)
Bickel, P.J., Doksum, K.A.: Mathematical Statistics. Holden-Day, San Francisco (1977)
Bolton, S.: Pharmaceutical Statistics: Practical and Clinical Applications, 3rd edn. Marcel Dekker, New York (1997)
Buncher, C.R., Tsay, J-Y.: Statistics in the Pharmaceutical Industry, 3rd edn. Chapman & Hall/CRC, Boca Raton (2006)
Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA) 2006 Amended
Conover, W.J.: Practical Nonparametric Statistics, 2nd edn. Wiley, New York (1980)
Lilliefore, H.W.: On the Kolmogorov Smirnov Test for Normality with Mean and Variance Unknown. J. Am. Stat. Assoc. 62, 399–402 (1967)
Mood, A.M.: On the asymptotic efficiency of certain non-parametric two-sample tests. Ann. Math. Stat. 25, 514–522 (1950)
Peace, K.E.: Biopharmaceutical Statistics for Drug Development. Marcel Dekker, New York (1987)
Peace, K.E.: Statistical Issues in Drug Research and Development. Marcel Dekker, New York (1990)
Ryan, T.A. Jr., Joiner, B.L.: Normal probability plots and tests for normality. Technical report, Statistics Department, The Pennsylvania State University (1976)
Wales J.: Animal testing. (2015). http://en.wikipedia.org/wiki/Animal_testing
WHO Technical Report Series 889. 48th Report, Amended (1999)
Zar, J.H.: Biostatistical Analysis, 3rd edn. Prentice Hall, Upper Saddle River (1996)
Acknowledgements
The author thanks M/s Bharat Biotech International Limited, Hyderabad, India, for providing the opportunity to work on this project and giving permission to publish this work in this book.
Author information
Authors and Affiliations
Appendix
Appendix
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Murthy, G.S.R. (2015). A Statistical Procedure for Minimizing In Vivo Tests for Quality Control of Vaccines. In: Applications of Operations Research and Management Science. International Series in Operations Research & Management Science, vol 229. Springer, Cham. https://doi.org/10.1007/978-3-319-17921-6_3
Download citation
DOI: https://doi.org/10.1007/978-3-319-17921-6_3
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-17920-9
Online ISBN: 978-3-319-17921-6
eBook Packages: Business and EconomicsBusiness and Management (R0)